INNOVATIVE RESEARCH & EDUCATION
The Institute for Biomedical Sciences is training future generations of leading biomedical scientists and professionals through a unique approach to education that highlights the connection among science, business and law and teaches sought-after, technical skills in our advanced labs. Our world-class researchers are tackling some of the most urgent human diseases such as COVID-19, developing new vaccines, diagnostics and therapeutics in research centers focused on microbial pathogenesis, translational immunology and inflammation, immunity and infection.
We've launched a new bachelor's degree program. The program prepares students for employment in the biomedical industry or advanced degrees in science, business or law. Learn More
Breakthroughs in Georgia: Enterprising Biomedicine
In a very short time, Georgia State University has built an impressive research enterprise. It’s the Institute for Biomedical Sciences, and its scientists are unlocking new insights and answers to an array of diseases and ailments. Tens of millions of dollars in research grants flow into the institute each year, and the university is planning even more expansion.
Research
Fighting Disease Threats
While humans have encountered some deadly viruses over the centuries such as influenza, Ebola, smallpox, SARS, MERS and HIV, there are inevitably new, life-threatening diseases out there waiting to emerge. Experts have agreed that it wasn’t a question of if – but when – another lethal infectious agent would occur and speculated if the world would be ready to fight it. Sadly, the answer is no.
Academic Programs
News Stories
More
Top Stories
Biomedical Sciences Researcher Gets COVID-19 Grant To Study Enzymes Critical for SARS-CoV-2 Replication
Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a $100,000 COVID-19 Fast Grant to study enzymes that are critical for the replication of SARS-CoV-2, the virus that causes COVID-19.read more ❯
Carving an Unknown Path
Sudeep Lama, a master’s degree student in the Institute for Biomedical Sciences, spent his summer working with an international medical device company to market a new diagnostic tool that will soon be available to help epilepsy patients.read more ❯
Biomedical Sciences Researcher Gets $2.94 Million Federal Grant To Study Unique Features of Ebola and Marburg Viruses
Dr. Christopher Basler, professor and director of the Center for Microbial Pathogenesis in the Institute for Biomedical Sciences at Georgia State University, has received a five-year, $2.94 million federal grant to study unique features of Ebola and Marburg viruses that control how the virus family expresses its genes and escapes immune responses.read more ❯